Zotarolimus-eluting stent-induced hypersensitivity pneumonitis
Hong-Won Shin, Chang-Wook Nam, Hyungseop Kim, Seung-Ho Hur, Yoon-Nyun Kim, Kwon-Bae Kim, Kun-Young Kwon
Korean J Intern Med. 2013;28(1):108-111. Published online 2012 Dec 28 DOI: https://doi.org/10.3904/kjim.2013.28.1.108
Citations to this article as recorded by 
Hypersensitivity and in-stent restenosis in coronary stent materials
Wansong Hu, Jun Jiang
Frontiers in Bioengineering and Biotechnology.2022;[Epub] CrossRef
Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs
Ana Dioun Broyles, Aleena Banerji, Sara Barmettler, Catherine M. Biggs, Kimberly Blumenthal, Patrick J. Brennan, Rebecca G. Breslow, Knut Brockow, Kathleen M. Buchheit, Katherine N. Cahill, Josefina Cernadas, Anca Mirela Chiriac, Elena Crestani, Pascal De
The Journal of Allergy and Clinical Immunology: In Practice.2020; 8(9): S16. CrossRef
Hypersensitivity pneumonitis: Antigen diversity and disease implications
R. Nogueira, N. Melo, H. Novais e Bastos, N. Martins, L. Delgado, A. Morais, P. C. Mota
Pulmonology.2019; 25(2): 97. CrossRef
Histopathological Differential Diagnosis of Optical Coherence Tomographic Image Interpretation After Stenting
Christoph Lutter, Hiroyoshi Mori, Kazuyuki Yahagi, Elena Ladich, Michael Joner, Robert Kutys, David Fowler, Maria Romero, Jagat Narula, Renu Virmani, Aloke V. Finn
JACC: Cardiovascular Interventions.2016; 9(24): 2511. CrossRef
Hypersensitivity Reaction in the US Food and Drug Administration–Approved Second-Generation Drug-Eluting Stents
Fumiyuki Otsuka, Kazuyuki Yahagi, Elena Ladich, Robert Kutys, Russell Alexander, David Fowler, Renu Virmani, Michael Joner
Circulation.2015; 131(3): 322. CrossRef
Cell viability of fibroblasts to pifenidone and sirolimus
Robert F.H. Walter, Paul Zarogoulidis, Fabian D. Mairinger, Robert Werner, Kaid Darwiche, Konstantinos Zarogoulidis, Lutz Freitag
International Journal of Pharmaceutics.2014; 466(1-2): 38. CrossRef